Unicycive Therapeutics, Inc. (UNCY)

CIK 1766140 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Unicycive Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097271
Aug 14, 2026SCHEDULE 13G/A0001213900-26-090075
Aug 12, 20268-K0001213900-26-088061
Aug 12, 202610-Q0001213900-26-088013
Jul 30, 2026SCHEDULE 13G0002012383-26-003117
Jul 28, 20264/A0001213900-26-082270
Jul 28, 20264/A0001213900-26-082273
Jul 8, 2026SCHEDULE 13G/A0001104659-26-081878
Jul 2, 20268-K0001213900-26-074678
Jul 1, 20261440001178937-26-000032
Jun 22, 20268-K0001213900-26-070316
Jun 22, 2026DEFA14A0001213900-26-070318
Jun 15, 20264/A0001213900-26-068920
Jun 15, 20264/A0001213900-26-068919
Jun 15, 2026EFFECT9999999995-26-001996
Jun 15, 20264/A0001213900-26-068922
Jun 15, 20264/A0001213900-26-068921
Jun 15, 20264/A0001213900-26-068915
Jun 15, 20264/A0001213900-26-068917
Jun 5, 20268-K0001213900-26-065828
Jun 5, 2026S-30001213900-26-065819
May 21, 202640001213900-26-060080
May 21, 202640001213900-26-060079
May 20, 202640001213900-26-059558
May 20, 202640001213900-26-059559